Impax Asset Management Group PLC Vertex Pharmaceuticals Inc Transaction History

Impax Asset Management Group PLC

  • $15.1 Billion
  • Q3 2025

A detailed history of Impax Asset Management Group PLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Impax Asset Management Group PLC holds 4,622 shares of VRTX stock, worth $1.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,622
Previous 4,622 -0.0%
Holding current value
$1.95 Million
Previous $2.06 Million 12.01%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
SELL
$421.16 - $509.5 $1 Million - $1.21 Million
-2,377 Reduced 33.96%
4,622 $2.06 Million
Q1 2025

Apr 29, 2025
BUY
$402.49 - $513.76 $30,186 - $38,532
75 Added 1.08%
6,999 $3.39 Million
Q4 2024

Feb 04, 2025
SELL
$396.64 - $516.74 $201,889 - $263,020
-509 Reduced 6.85%
6,924 $2.79 Million
Q3 2024

Oct 30, 2024
SELL
$460.0 - $505.78 $21.1 Million - $23.2 Million
-45,963 Reduced 86.08%
7,433 $3.46 Million
Q2 2024

Nov 08, 2024
BUY
$392.81 - $485.53 $18.1 Million - $22.3 Million
45,963 Added 618.36%
53,396 $25 Million
Q2 2024

Aug 05, 2024
SELL
$392.81 - $485.53 $5.64 Million - $6.97 Million
-14,362 Reduced 21.2%
53,396 $25 Million
Q1 2024

Apr 30, 2024
SELL
$407.69 - $446.08 $6.75 Million - $7.38 Million
-16,555 Reduced 19.64%
67,758 $28.3 Million
Q4 2023

Jan 26, 2024
SELL
$343.0 - $410.68 $163 Million - $195 Million
-473,825 Reduced 84.89%
84,313 $34.3 Million
Q3 2023

Nov 07, 2023
SELL
$338.18 - $362.46 $8.72 Million - $9.34 Million
-25,782 Reduced 4.42%
558,138 $194 Million
Q2 2023

Aug 07, 2023
SELL
$314.42 - $351.91 $56.1 Million - $62.8 Million
-178,427 Reduced 23.4%
583,920 $205 Million
Q1 2023

May 10, 2023
SELL
$283.23 - $323.1 $471,294 - $537,638
-1,664 Reduced 0.22%
762,347 $240 Million
Q4 2022

Feb 09, 2023
BUY
$285.76 - $321.48 $18.9 Million - $21.3 Million
66,278 Added 9.5%
764,011 $221 Million
Q3 2022

Nov 08, 2022
SELL
$273.83 - $305.53 $6.35 Million - $7.09 Million
-23,201 Reduced 3.22%
697,733 $202 Million
Q2 2022

Aug 11, 2022
SELL
$234.96 - $292.55 $32.8 Million - $40.9 Million
-139,738 Reduced 16.24%
720,934 $203 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $38.1 Million - $44.9 Million
-172,183 Reduced 16.67%
860,672 $225 Million
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $7.41 Million - $9.36 Million
-41,881 Reduced 3.9%
1,032,855 $227 Million
Q3 2021

Nov 12, 2021
BUY
$181.39 - $202.99 $57.9 Million - $64.8 Million
319,209 Added 42.25%
1,074,736 $195 Million
Q2 2021

Aug 05, 2021
BUY
$187.49 - $221.1 $125 Million - $147 Million
666,559 Added 749.21%
755,527 $152 Million
Q1 2021

May 14, 2021
BUY
$207.02 - $241.31 $2.77 Million - $3.23 Million
13,396 Added 17.73%
88,968 $19.1 Million
Q4 2020

Feb 16, 2021
BUY
$207.01 - $276.09 $2.15 Million - $2.87 Million
10,381 Added 15.92%
75,572 $17.9 Million
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $4.77 Million - $5.65 Million
18,641 Added 40.05%
65,191 $17.7 Million
Q2 2020

Aug 14, 2020
SELL
$225.48 - $295.8 $1.38 Million - $1.81 Million
-6,121 Reduced 11.62%
46,550 $13.5 Million
Q1 2020

May 15, 2020
BUY
$199.77 - $247.81 $1.57 Million - $1.95 Million
7,880 Added 17.59%
52,671 $12.5 Million
Q4 2019

Feb 13, 2020
BUY
$166.71 - $223.91 $78,020 - $104,789
468 Added 1.06%
44,791 $9.81 Million
Q3 2019

Nov 14, 2019
BUY
$166.23 - $187.09 $6.6 Million - $7.43 Million
39,709 Added 860.62%
44,323 $7.51 Million
Q2 2019

Aug 13, 2019
BUY
$164.61 - $190.37 $73,086 - $84,524
444 Added 10.65%
4,614 $846,000
Q1 2019

May 13, 2019
BUY
$163.73 - $194.7 $115,102 - $136,874
703 Added 20.28%
4,170 $767,000
Q4 2018

Feb 14, 2019
BUY
$151.91 - $192.21 $10,026 - $12,685
66 Added 1.94%
3,467 $575,000
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $570,449 - $655,508
3,401 New
3,401 $656,000

Others Institutions Holding VRTX

# of Institutions
1,790
Shares Held
236M
Call Options Held
1.95M
Put Options Held
1.14M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $108B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Impax Asset Management Group PLC Portfolio

Follow Impax Asset Management Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email